healthcare
healthcare Articles
Amyris shares jumped on Friday after the firm announced that it has successfully delivered on its first milestone for its cannabinoid partner, Lavvan.
Published:
Last Updated:
Tricida shares jumped on Thursday after the firm announced results from its chronic kidney disease study.
Published:
Last Updated:
Proteon Therapeutics shares were absolutely crushed on Thursday after the firm announced results from its late-stage trial in patients with chronic kidney disease.
Published:
Last Updated:
Amyris shares ended Wednesday on a very positive note despite the broad markets lagging. The company reiterated guidance for its coming quarter as well as saying that it will discuss its future...
Published:
Last Updated:
This is one of those mergers that is not getting the warm fuzzy feeling that management teams love to see.
Published:
Last Updated:
Axsome shares jumped on Wednesday after the firm gave an update from the FDA regarding its AXS-05 for the treatment of major depressive disorder.
Published:
Last Updated:
The March 15 short interest data have been compared with the previous figures, and short interest moves in these selected marijuana stocks were mixed.
Published:
Last Updated:
The March 15 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks decreased, with two major movers in the group.
Published:
Last Updated:
The March 15 short interest data have been compared with the previous report, and short interest in most of the selected biotech stocks decreased.
Published:
Last Updated:
It seems that cannabis stocks such as Canopy Growth and Tilray have become more normalized in the United States and legislation is on the way.
Published:
Last Updated:
Curis shares jumped when the firm announced that it entered into an agreement to sell rights to a portion of royalty revenues on worldwide net sales of Erivedge.
Published:
Last Updated:
Biogen shares made a slight gain early on Monday after the firm made an SEC filing indicating that it will be buying back a sizable amount of stock.
Published:
Last Updated:
Biogen shares were crushed in Thursday’s session after the firm announced that it would be discontinuing its late-stage trial for Alzheimer’s disease.
Published:
Last Updated:
Pfizer is looking to collaborate with Vivet on the development of its proprietary treatment for Wilson disease.
Published:
Last Updated:
Altimmune shares surged on Tuesday following results from its midstage study of a intranasal influenza vaccine candidate.
Published:
Last Updated: